Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Knut Eis

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Drug Discovery Today|May 23, 2006
Automated medicinal chemistryMarcus Koppitz, Knut Eis
Chembiochem : a European Journal of Chemical Biology|February 16, 2005
Kinase data mining: dealing with the information (over-)flowKnut Eis, Stuart J Ince, Carsten Jahn, et al.
Molecular Biology of the Cell|August 3, 2007
Use of the novel Plk1 inhibitor ZK-thiazolidinone to elucidate functions of Plk1 in early and late stages of mitosisAnna Santamaria, Rüdiger Neef, Uwe Eberspächer, et al.
Cancer Letters|January 4, 2017
BAY 1143269, a novel MNK1 inhibitor, targets oncogenic protein expression and shows potent anti-tumor activitySusann Santag, Franziska Siegel, Antje M Wengner, et al.
Chemmedchem|April 3, 2020
Computationally Empowered Workflow Identifies Novel Covalent Allosteric Binders for KRAS<sup>G12C</sup>Jérémie Mortier, Anders Friberg, Volker Badock, et al.
Journal of Medicinal Chemistry|October 21, 2022
Discovery and Structure-Based Design of Potent Covalent PPARγ Inverse-Agonists <b>BAY-4931</b> and <b>BAY-0069</b>Douglas L Orsi, Elisabeth Pook, Nico Bräuer, et al.
Journal of Medicinal Chemistry|December 21, 2022
Correction to "Discovery and Structure-Based Design of Potent Covalent PPARγ Inverse-Agonists BAY-4931 and BAY-0069"Douglas L Orsi, Elisabeth Pook, Nico Bräuer, et al.
Iscience|September 14, 2020
Identification of Small Molecules that Modulate Mutant p53 CondensationClara Lemos, Luise Schulze, Joerg Weiske, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 27, 2019
Discovery of potent SOS1 inhibitors that block RAS activation via disruption of the RAS-SOS1 interactionRoman C Hillig, Brice Sautier, Jens Schroeder, et al.
Journal of Medicinal Chemistry|August 24, 2021
BAY-8400: A Novel Potent and Selective DNA-PK Inhibitor which Shows Synergistic Efficacy in Combination with Targeted Alpha TherapiesMarkus Berger, Lars Wortmann, Philipp Buchgraber, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Drug Discovery Today|May 23, 2006
Automated medicinal chemistryMarcus Koppitz, Knut Eis
Chembiochem : a European Journal of Chemical Biology|February 16, 2005
Kinase data mining: dealing with the information (over-)flowKnut Eis, Stuart J Ince, Carsten Jahn, et al.
Molecular Biology of the Cell|August 3, 2007
Use of the novel Plk1 inhibitor ZK-thiazolidinone to elucidate functions of Plk1 in early and late stages of mitosisAnna Santamaria, Rüdiger Neef, Uwe Eberspächer, et al.
Cancer Letters|January 4, 2017
BAY 1143269, a novel MNK1 inhibitor, targets oncogenic protein expression and shows potent anti-tumor activitySusann Santag, Franziska Siegel, Antje M Wengner, et al.
Chemmedchem|April 3, 2020
Computationally Empowered Workflow Identifies Novel Covalent Allosteric Binders for KRAS<sup>G12C</sup>Jérémie Mortier, Anders Friberg, Volker Badock, et al.
Journal of Medicinal Chemistry|October 21, 2022
Discovery and Structure-Based Design of Potent Covalent PPARγ Inverse-Agonists <b>BAY-4931</b> and <b>BAY-0069</b>Douglas L Orsi, Elisabeth Pook, Nico Bräuer, et al.
Journal of Medicinal Chemistry|December 21, 2022
Correction to "Discovery and Structure-Based Design of Potent Covalent PPARγ Inverse-Agonists BAY-4931 and BAY-0069"Douglas L Orsi, Elisabeth Pook, Nico Bräuer, et al.
Iscience|September 14, 2020
Identification of Small Molecules that Modulate Mutant p53 CondensationClara Lemos, Luise Schulze, Joerg Weiske, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 27, 2019
Discovery of potent SOS1 inhibitors that block RAS activation via disruption of the RAS-SOS1 interactionRoman C Hillig, Brice Sautier, Jens Schroeder, et al.
Journal of Medicinal Chemistry|August 24, 2021
BAY-8400: A Novel Potent and Selective DNA-PK Inhibitor which Shows Synergistic Efficacy in Combination with Targeted Alpha TherapiesMarkus Berger, Lars Wortmann, Philipp Buchgraber, et al.
Pageof 2